# Seroprevalence of SARS CoV 2 Antibodies in Previously Undiagnosed Healthcare Workers

> **NCT04383587** · NA · COMPLETED · sponsor: **Mayo Clinic** · enrollment: 300 (actual)

## Conditions studied

- SARS-CoV 2
- COVID-19

## Interventions

- **OTHER:** Serologic testing

## Key facts

- **NCT ID:** NCT04383587
- **Lead sponsor:** Mayo Clinic
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-05-06
- **Primary completion:** 2020-07-01
- **Final completion:** 2020-07-31
- **Target enrollment:** 300 (ACTUAL)
- **Last updated:** 2022-04-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04383587

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04383587, "Seroprevalence of SARS CoV 2 Antibodies in Previously Undiagnosed Healthcare Workers". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT04383587. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*